Skip to main content
Premium Trial:

Request an Annual Quote

UK s LGC Gets 2 Million to Develop New Biotech Tools

NEW YORK, July 31-The UK analytical lab service company LGC won more than £2 million in government contracts to develop microarray technology, mass spectrometry methods and other genomic and proteomic research tools, the company said today.


To improve microarray technology, LGC will work with various academic and industrial partners to evaluate the performance and comparability of various microarray systems.


With a £550,000 proteomics grant, LGC researchers will study isotope labeling in mass spectrometry.


Other grants will fund an effort to improve cell-based assays for hepatotoxicity and drug metabolism and a project to validate ultrasound spectroscopy for protein measurement.


The UK Department of Trade and Industry granted these contracts under its Measurements for Biology program, which is designed to improve measurement techniques and standardization in biotechnology.


LGC, based in Teddington, Middlesex, offers analytical and diagnostic lab services for clinical applications and laboratory research.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.